These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 32670862)
21. STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma. Tai WT; Chu PY; Shiau CW; Chen YL; Li YS; Hung MH; Chen LJ; Chen PL; Su JC; Lin PY; Yu HC; Chen KF Clin Cancer Res; 2014 Nov; 20(22):5768-76. PubMed ID: 25248379 [TBL] [Abstract][Full Text] [Related]
22. Down-regulation of sphingosine kinase 2 (SphK2) increases the effects of all-trans-retinoic acid (ATRA) on colon cancer cells. Chu JH; Gao ZH; Qu XJ Biomed Pharmacother; 2014 Oct; 68(8):1089-97. PubMed ID: 25455157 [TBL] [Abstract][Full Text] [Related]
23. Sphingosine kinase 2 is a negative regulator of inflammatory macrophage activation. Weigert A; von Knethen A; Thomas D; Faria I; Namgaladze D; Zezina E; Fuhrmann D; Petcherski A; Heringdorf DMZ; Radeke HH; Brüne B Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Sep; 1864(9):1235-1246. PubMed ID: 31128248 [TBL] [Abstract][Full Text] [Related]
24. Sphingosine kinase 2 cooperating with Fyn promotes kidney fibroblast activation and fibrosis via STAT3 and AKT. Zhu X; Shi D; Cao K; Ru D; Ren J; Rao Z; Chen Y; You Q; Dai C; Liu L; Zhou H Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3824-3836. PubMed ID: 30251698 [TBL] [Abstract][Full Text] [Related]
25. ABC294640, A Novel Sphingosine Kinase 2 Inhibitor, Induces Oncogenic Virus-Infected Cell Autophagic Death and Represses Tumor Growth. Dai L; Bai A; Smith CD; Rodriguez PC; Yu F; Qin Z Mol Cancer Ther; 2017 Dec; 16(12):2724-2734. PubMed ID: 28939554 [TBL] [Abstract][Full Text] [Related]
26. Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo. Song K; Dai L; Long X; Cui X; Liu Y; Di W Onco Targets Ther; 2019; 12():4437-4449. PubMed ID: 31239712 [No Abstract] [Full Text] [Related]
27. Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression. Xu J; Huang F; Yao Z; Jia C; Xiong Z; Liang H; Lin N; Deng M Cell Commun Signal; 2019 Jul; 17(1):85. PubMed ID: 31349793 [TBL] [Abstract][Full Text] [Related]
28. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo. Urtz N; Gaertner F; von Bruehl ML; Chandraratne S; Rahimi F; Zhang L; Orban M; Barocke V; Beil J; Schubert I; Lorenz M; Legate KR; Huwiler A; Pfeilschifter JM; Beerli C; Ledieu D; Persohn E; Billich A; Baumruker T; Mederos y Schnitzler M; Massberg S Circ Res; 2015 Jul; 117(4):376-87. PubMed ID: 26129975 [TBL] [Abstract][Full Text] [Related]
29. Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640. White MD; Chan L; Antoon JW; Beckman BS Anticancer Res; 2013 Sep; 33(9):3573-9. PubMed ID: 24023282 [TBL] [Abstract][Full Text] [Related]
30. Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma. Maceyka M; Rohrbach T; Milstien S; Spiegel S Handb Exp Pharmacol; 2020; 259():3-17. PubMed ID: 31321542 [TBL] [Abstract][Full Text] [Related]
32. The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo. Dai L; Smith CD; Foroozesh M; Miele L; Qin Z Int J Cancer; 2018 May; 142(10):2153-2162. PubMed ID: 29277894 [TBL] [Abstract][Full Text] [Related]
33. Induction of Apoptosis, Inhibition of MCL-1, and VEGF-A Expression Are Associated with the Anti-Cancer Efficacy of Magnolol Combined with Regorafenib in Hepatocellular Carcinoma. Chen CH; Hsu FT; Chen WL; Chen JH Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922992 [TBL] [Abstract][Full Text] [Related]
34. Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention. Grbčić P; Car EPM; Sedić M Curr Med Chem; 2020; 27(39):6611-6627. PubMed ID: 31544710 [TBL] [Abstract][Full Text] [Related]
35. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells. Schnitzer SE; Weigert A; Zhou J; Brüne B Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180 [TBL] [Abstract][Full Text] [Related]
36. Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice. Lo J; Lau EY; Ching RH; Cheng BY; Ma MK; Ng IO; Lee TK Hepatology; 2015 Aug; 62(2):534-45. PubMed ID: 25902734 [TBL] [Abstract][Full Text] [Related]
37. Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells. Wu LW; Zhou DM; Zhang ZY; Zhang JK; Zhu HJ; Lin NM; Zhang C Biochem Biophys Res Commun; 2019 May; 512(4):852-858. PubMed ID: 30929918 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of SphK2 Stimulated Hepatic Gluconeogenesis Associated with Dephosphorylation and Deacetylation of STAT3. Yuan J; Qiao J; Mu B; Lin L; Qiao L; Yan L; Shi Y Arch Med Res; 2018 Jul; 49(5):335-341. PubMed ID: 30448236 [TBL] [Abstract][Full Text] [Related]
39. Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells. Refolo MG; Lippolis C; Carella N; Cavallini A; Messa C; D'Alessandro R Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783729 [TBL] [Abstract][Full Text] [Related]
40. The ceramide synthase 2b gene mediates genomic sensing and regulation of sphingosine levels during zebrafish embryogenesis. Mendelson K; Pandey S; Hisano Y; Carellini F; Das BC; Hla T; Evans T Elife; 2017 Sep; 6():. PubMed ID: 28956531 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]